Lung Transplant News and Research

RSS
A pulmonary transplant (or lung transplant) is a surgical procedure in which a diseased lung is removed and replaced with a healthy lung from a donor. A lung transplant will often be recommended if a person has advanced lung disease that is unresponsive to other treatments and/or when a person's life expectancy is likely less than 2-3 years. A lung transplant is considered for those suffering from the following conditions:
Memorial mass for former Loyola University Hospital cardiothoracic surgeon

Memorial mass for former Loyola University Hospital cardiothoracic surgeon

Study indicates vitamin D deficiency may increase lung transplant rejection

Study indicates vitamin D deficiency may increase lung transplant rejection

Alnylam Pharmaceuticals publishes ALN-RSV01 Phase IIa study results

Alnylam Pharmaceuticals publishes ALN-RSV01 Phase IIa study results

Circadian partners with Cincinnati Children's Hospital to develop blood test diagnostic for LAM, a serious lung disease

Circadian partners with Cincinnati Children's Hospital to develop blood test diagnostic for LAM, a serious lung disease

U.S. joins whistleblower suit against Pfizer for drug marketing

U.S. joins whistleblower suit against Pfizer for drug marketing

Scientist develops new ETS procedure to treat hyperhidrosis

Scientist develops new ETS procedure to treat hyperhidrosis

Non-kidney transplant patients likely to undergo kidney transplant prior to dialysis: Study

Non-kidney transplant patients likely to undergo kidney transplant prior to dialysis: Study

St. Vincent's Hospital performs Australia's first implant of SynCardia temporary Total Artificial Heart

St. Vincent's Hospital performs Australia's first implant of SynCardia temporary Total Artificial Heart

Australia’s first artificial heart in place

Australia’s first artificial heart in place

PFF announces introduction of Pulmonary Fibrosis Research Enhancement Act in US Senate

PFF announces introduction of Pulmonary Fibrosis Research Enhancement Act in US Senate

Alnylam second-quarter revenues increase to $26.6 million

Alnylam second-quarter revenues increase to $26.6 million

CPF announces nationwide advertising campaign to increase awareness about PF

CPF announces nationwide advertising campaign to increase awareness about PF

First triple-organ transplantation performed on young Brenham resident at Texas Children's Hospital

First triple-organ transplantation performed on young Brenham resident at Texas Children's Hospital

Researchers examine impact of genetic ancestry on measures of lung function

Researchers examine impact of genetic ancestry on measures of lung function

Successful growth of mouse embryonic stem cells in rat lungs raises hopes for engineering human transplants

Successful growth of mouse embryonic stem cells in rat lungs raises hopes for engineering human transplants

NBC's TODAY Show to focus on PF in an interview with a patient from California

NBC's TODAY Show to focus on PF in an interview with a patient from California

RNAi therapy shuts down gene critical to RSV, prevents virus replication

RNAi therapy shuts down gene critical to RSV, prevents virus replication

Alnylam Pharmaceuticals reports consolidated financial results for first quarter 2010

Alnylam Pharmaceuticals reports consolidated financial results for first quarter 2010

Alnylam Pharmaceuticals publishes encouraging results from Phase II GEMINI study in PNAS

Alnylam Pharmaceuticals publishes encouraging results from Phase II GEMINI study in PNAS

IL-10 Gene Therapy helps repair damaged lungs found unfit for transplant

IL-10 Gene Therapy helps repair damaged lungs found unfit for transplant

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.